Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
Erika Jensen‐Jarolim, Martin F. Bachmann, С. Бонини, et al.
Allergy (2019) Vol. 75, Iss. 4, pp. 746-760
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 236
Mechanisms of allergen-specific immunotherapy and allergen tolerance
Umut Can Küçüksezer, Cevdet Özdemir, Lacin Cevhertas, et al.
Allergology International (2020) Vol. 69, Iss. 4, pp. 549-560
Open Access | Times Cited: 141
Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well‐Tolerated in a Pivotal Phase III Trial
Stefan Zielen, Jonathan A. Bernstein, Gunter J. Sturm, et al.
Allergy (2025)
Open Access | Times Cited: 2
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Dysregulation of the epithelial barrier by environmental and other exogenous factors
Yasutaka Mitamura, İsmail Öğülür, Yağız Pat, et al.
Contact Dermatitis (2021) Vol. 85, Iss. 6, pp. 615-626
Open Access | Times Cited: 57
Novel adjuvants in allergen-specific immunotherapy: where do we stand?
Yen‐Ju Lin, Jennifer Zimmermann, Stefan Schülke
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring
Cristina Benito‐Villalvilla, Mario Pérez‐Diego, Alba Angelina, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 1, pp. 212-222.e9
Open Access | Times Cited: 49
Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy
Qi Liu, Guoqiang Chen, Xingchi Liu, et al.
ACS Nano (2024)
Open Access | Times Cited: 6
Tolerance mechanisms in allergen immunotherapy
Zeynep Çelebi Sözener, Dilşad Mungan, Lacin Cevhertas, et al.
Current Opinion in Allergy and Clinical Immunology (2020) Vol. 20, Iss. 6, pp. 591-601
Closed Access | Times Cited: 40
Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience
Erika Jensen‐Jarolim, Franziska Roth‐Walter, Galateja Jordakieva, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 5, pp. 1780-1789
Open Access | Times Cited: 38
Predicting Success of Allergen-Specific Immunotherapy
Ulrich M. Zissler, Carsten B. Schmidt‐Weber
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 34
Global implementation of the world health organization's International Classification of Diseases (ICD)‐11: The allergic and hypersensitivity conditions model
Luciana Kase Tanno, R.J.G. Chalmers, Robert Jacob, et al.
Allergy (2020) Vol. 75, Iss. 9, pp. 2206-2218
Open Access | Times Cited: 33
Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling
Thierry Batard, Giorgio Walter Canonica, Oliver Pfaar, et al.
Molecular Immunology (2023) Vol. 155, pp. 124-134
Closed Access | Times Cited: 12
When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment
Mario Wenger, Sophie Grosse-Kathoefer, Amin Kraiem, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
Antonio Nieto, Ángel Mazón, María Nieto, et al.
Allergy (2022) Vol. 77, Iss. 10, pp. 3096-3107
Open Access | Times Cited: 17
Progress towards Adjuvant Development: Focus on Antiviral Therapy
Annalaura Brai, Federica Poggialini, Claudia Pasqualini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9225-9225
Open Access | Times Cited: 10
Advances in Allergen Immunotherapy and Safety
Samia T. Al‐Shouli
Vaccines (2025) Vol. 13, Iss. 3, pp. 221-221
Open Access
The Potential of Exosomes in Allergy Immunotherapy
Paul Engeroff, Monique Vogel
Vaccines (2022) Vol. 10, Iss. 1, pp. 133-133
Open Access | Times Cited: 16
Elevated aluminum excretion in patients by long-term subcutaneous immunotherapy – A cross-sectional case-control study
Julia Hiller, Thomas Göen, Hans Drexler, et al.
International Journal of Hygiene and Environmental Health (2024) Vol. 258, pp. 114337-114337
Open Access | Times Cited: 3
Molecular approaches to allergen‐specific immunotherapy: Are we so far from clinical implementation?
Phornsiri Pechsrichuang, Alain Jacquet
Clinical & Experimental Allergy (2020) Vol. 50, Iss. 5, pp. 543-557
Closed Access | Times Cited: 21
Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
Diego Pazos‐Castro, Clémence Margain, Zulema González‐Klein, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)
Matthew D. Heath, Mona O. Mohsen, Pieter‐Jan de Kam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 19
Purified Free Mannan Promotes Tolerogenic Responses in Peanut-Stimulated Human Dendritic Cells
Silvia A. Sánchez‐Herrero, Cristina Benito‐Villalvilla, Óscar Palomares
International Archives of Allergy and Immunology (2024) Vol. 185, Iss. 7, pp. 652-658
Closed Access | Times Cited: 2
Heterogenous Induction of Blocking Antibodies against Ragweed Allergen Molecules by Allergen Extract-Based Immunotherapy Vaccines
Lauriana‐Eunice Zbîrcea, Maria Roxana Buzan, Manuela Grijincu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 635-635
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top